Total investments received (USD): 2.98m
Round value (USD): 2.98m
Company: Pharmanest
Industry:
Health services
Pharma

Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom